Salman Abdul Waheed, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2614 W Jefferson St, Joliet, IL 60435 Phone: 815-725-1355 Fax: 815-725-9861 |
Ellen J Gustafson, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2614 W Jefferson St, Joliet, IL 60435 Phone: 815-725-1355 Fax: 815-725-9857 |
Worood Abboud, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2614 W. Jefferson St, Joliet, IL 60435 Phone: 815-725-1355 Fax: 815-725-9857 |
Dr. Nina Yedavalli, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1301 Copperfield Ave, Suite 105, Joliet, IL 60432 Phone: 815-740-1400 |
Sarode K Pundaleeka, MD Internal Medicine - Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 2614 W Jefferson St, Joliet, IL 60435 Phone: 815-725-1355 Fax: 815-725-9857 |
Ali R Lakhani, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2614 W Jefferson St, Joliet, IL 60435 Phone: 815-725-1355 Fax: 815-725-9857 |
Nafisa D Burhani, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2614 W Jefferson St, Joliet, IL 60435 Phone: 815-725-1355 Fax: 815-725-9857 |
Kulumani M Sivarajan, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2614 W Jefferson St, Joliet, IL 60435 Phone: 815-725-1355 Fax: 815-725-9857 |
News Archive
Leading scientists from the UK and around the world will meet at the University of Southampton next week (20 and 21 July) to discuss new technologies to create new, living tissues in the lab and to help our bodies regenerate themselves.
LABS, Inc., a global, full-service testing laboratory with more than 30 years of expertise in regulated testing for human organs, cells, tissues and implantable biologic products and devices, today announced that it has been granted AABB Accreditation for donor testing.
A drug already used safely to treat Parkinson's disease, restless leg syndrome and other movement disorders also could delay or prevent the most common cause of blindness affecting more than 9 million older Americans - age-related macular degeneration (AMD).
How can insurers justify spending hundreds of thousands of dollars per patient per year on "orphan drugs" - extremely expensive medications for rare conditions that are mostly chronic and life-threatening - when this money could provide greater overall health benefit if spread out among many other patients?
A team of researchers from the Cleveland Clinic Lerner Research Institute have found that gradually depleting an enzyme called BACE1 completely reverses the formation of amyloid plaques in the brains of mice with Alzheimer's disease, thereby improving the animals' cognitive function.
› Verified 1 days ago